137 related articles for article (PubMed ID: 9852281)
1. Retrovirus-mediated gene therapy for human hepatocellular carcinoma transplanted in athymic mice.
Ueki T; Nakata K; Mawatari F; Tsuruta S; Ido A; Ishikawa H; Nakao K; Kato Y; Ishii N; Eguchi K
Int J Mol Med; 1998 Apr; 1(4):671-5. PubMed ID: 9852281
[TBL] [Abstract][Full Text] [Related]
2. Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoter.
Mawatari F; Tsuruta S; Ido A; Ueki T; Nakao K; Kato Y; Tamaoki T; Ishii N; Nakata K
Cancer Gene Ther; 1998; 5(5):301-6. PubMed ID: 9824049
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter.
Ido A; Nakata K; Kato Y; Nakao K; Murata K; Fujita M; Ishii N; Tamaoki T; Shiku H; Nagataki S
Cancer Res; 1995 Jul; 55(14):3105-9. PubMed ID: 7541712
[TBL] [Abstract][Full Text] [Related]
4. Utilization of variant-type of human alpha-fetoprotein promoter in gene therapy targeting for hepatocellular carcinoma.
Ishikawa H; Nakata K; Mawatari F; Ueki T; Tsuruta S; Ido A; Nakao K; Kato Y; Ishii N; Eguchi K
Gene Ther; 1999 Apr; 6(4):465-70. PubMed ID: 10476206
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter.
Ido A; Uto H; Moriuchi A; Nagata K; Onaga Y; Onaga M; Hori T; Hirono S; Hayashi K; Tamaoki T; Tsubouchi H
Cancer Res; 2001 Apr; 61(7):3016-21. PubMed ID: 11306481
[TBL] [Abstract][Full Text] [Related]
6. Retrovirus-mediated gene therapy for hepatocellular carcinoma with reversely oriented therapeutic gene expression regulated by alpha-fetoprotein enhancer/promoter.
Ishikawa H; Nakata K; Mawatari F; Ueki T; Tsuruta S; Ido A; Nakao K; Kato Y; Ishii N; Eguchi K
Biochem Biophys Res Commun; 2001 Oct; 287(4):1034-40. PubMed ID: 11573968
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene.
Kanai F; Shiratori Y; Yoshida Y; Wakimoto H; Hamada H; Kanegae Y; Saito I; Nakabayashi H; Tamaoki T; Tanaka T; Lan KH; Kato N; Shiina S; Omata M
Hepatology; 1996 Jun; 23(6):1359-68. PubMed ID: 8675152
[TBL] [Abstract][Full Text] [Related]
8. Assessment of α-fetoprotein targeted HSV1-tk expression in hepatocellular carcinoma with in vivo imaging.
Park JH; Kim KI; Lee KC; Lee YJ; Lee TS; Chung WS; Lim SM; Kang JH
Cancer Biother Radiopharm; 2015 Feb; 30(1):8-15. PubMed ID: 25545853
[TBL] [Abstract][Full Text] [Related]
9. Selective killing of AFP-positive hepatocellular carcinoma cells by adeno-associated virus transfer of the herpes simplex virus thymidine kinase gene.
Su H; Chang JC; Xu SM; Kan YW
Hum Gene Ther; 1996 Mar; 7(4):463-70. PubMed ID: 8800740
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy for hepatocellular carcinoma based on tumour-selective suicide gene expression using the alpha-fetoprotein (AFP) enhancer and a housekeeping gene promoter.
Cao G; Kuriyama S; Gao J; Nakatani T; Chen Q; Yoshiji H; Zhao L; Kojima H; Dong Y; Fukui H; Hou J
Eur J Cancer; 2001 Jan; 37(1):140-7. PubMed ID: 11165141
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression.
Kaneko S; Hallenbeck P; Kotani T; Nakabayashi H; McGarrity G; Tamaoki T; Anderson WF; Chiang YL
Cancer Res; 1995 Nov; 55(22):5283-7. PubMed ID: 7585589
[TBL] [Abstract][Full Text] [Related]
12. Complete cure of established murine hepatocellular carcinoma is achievable by repeated injections of retroviruses carrying the herpes simplex virus thymidine kinase gene.
Kuriyama S; Masui K; Kikukawa M; Sakamoto T; Nakatani T; Nagao S; Yamazaki M; Yoshiji H; Tsujinoue H; Fukui H; Yoshimatsu T; Ikenaka K
Gene Ther; 1999 Apr; 6(4):525-33. PubMed ID: 10476212
[TBL] [Abstract][Full Text] [Related]
13. Tissue-specific expression of herpes simplex virus thymidine kinase gene delivered by adeno-associated virus inhibits the growth of human hepatocellular carcinoma in athymic mice.
Su H; Lu R; Chang JC; Kan YW
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13891-6. PubMed ID: 9391123
[TBL] [Abstract][Full Text] [Related]
14. Retrovirus-mediated herpes simplex virus thymidine kinase gene therapy approach for hepatocellular carcinoma.
Gao Ding Cheng ; An W; Dai J
Cell Res; 1999 Sep; 9(3):225-35. PubMed ID: 10520605
[TBL] [Abstract][Full Text] [Related]
15. Hepatoma-specific gene therapy through retrovirus-mediated and targeted gene transfer using an adenovirus carrying the ecotropic receptor gene.
Uto H; Ido A; Hori T; Hirono S; Hayashi K; Tamaoki T; Tsubouchi H
Biochem Biophys Res Commun; 1999 Nov; 265(2):550-5. PubMed ID: 10558907
[TBL] [Abstract][Full Text] [Related]
16. Eradication of hepatocellular carcinoma xenografts by radiolabelled, lipiodol-inducible gene therapy.
Kawashita Y; Ohtsuru A; Miki F; Kuroda H; Morishita M; Kaneda Y; Hatsushiba K; Kanematsu T; Yamashita S
Gene Ther; 2005 Nov; 12(22):1633-9. PubMed ID: 16079887
[TBL] [Abstract][Full Text] [Related]
17. HVJ-liposome-mediated transfection of HSVtk gene driven by AFP promoter inhibits hepatic tumor growth of hepatocellular carcinoma in SCID mice.
Hirano T; Kaneko S; Kaneda Y; Saito I; Tamaoki T; Furuyama J; Tamaoki T; Kobayashi K; Ueki T; Fujimoto J
Gene Ther; 2001 Jan; 8(1):80-3. PubMed ID: 11402306
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy for hepatocellular carcinoma: chemosensitivity conferred by adenovirus-mediated transfer of the HSV-1 thymidine kinase gene.
Wills KN; Huang WM; Harris MP; Machemer T; Maneval DC; Gregory RJ
Cancer Gene Ther; 1995 Sep; 2(3):191-7. PubMed ID: 8528962
[TBL] [Abstract][Full Text] [Related]
19. [Effects of retrovirus-mediated HSV-tk/GCV on human hepatocellular carcinoma].
Zhao Y; Zhang X; Hui H
Zhonghua Gan Zang Bing Za Zhi; 1999 Jun; 7(2):113-5. PubMed ID: 10488424
[TBL] [Abstract][Full Text] [Related]
20. Retrovirus-mediated in vivo gene therapy using the herpes simplex virus thymidine kinase gene against carcinomatous peritonitis.
Toyokawa Y; Kuriyama S; Tsujinoue H; Nakatani T; Mitoro A; Yoshiji H; Fukui H
Scand J Gastroenterol; 2000 Aug; 35(8):852-60. PubMed ID: 10994625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]